Related Experiment Video
Updated: May 10, 2026

The Use of Reverse Phase Protein Arrays RPPA to Explore Protein Expression Variation within Individual Renal Cell Cancers
Published on: January 22, 2013
Staging and imaging-based prognostication in renal cell carcinoma: current guidelines and practical considerations
Yuki Arita1,2, Anton Becker3, Doris Leithner3
1Department of Radiology, University of California, San Francisco, San Francisco, USA. yukiarita1113@gmail.com.
Advanced imaging techniques improve renal cell carcinoma (RCC) staging by integrating prognostic markers. This enhances preoperative risk assessment and patient management for better outcomes.
Area of Science:
- Radiology and Oncology
- Medical Imaging
- Urologic Oncology
Background:
- Anatomical staging alone is insufficient for renal cell carcinoma (RCC) management, as it doesn't fully represent tumor biology.
- Computed tomography (CT) and magnetic resonance imaging (MRI) are crucial for RCC staging, but their application and interpretation can vary.
- Integrating imaging-based prognostic markers offers a more comprehensive approach to assessing tumor aggressiveness and patient risk.
Purpose of the Study:
- To review the current use of CT and MRI for RCC T-staging according to major guidelines.
- To explore the role of imaging-based prognostic biomarkers in refining preoperative risk assessment for RCC.
- To discuss future directions in advanced imaging and standardized reporting for RCC management.
Main Methods:
- Review of multiphase CT and MRI protocols for T-staging in RCC.
- Analysis of imaging-based prognostic biomarkers (e.g., enhancement patterns, diffusion metrics, radiomics).
- Comparison of imaging recommendations across American Urological Association, European Association of Urology, and National Comprehensive Cancer Network guidelines.
Main Results:
- Multiphase CT and MRI are pragmatically used for T-staging, with identified pitfalls.
- Imaging biomarkers like central non-enhancement and enhancement heterogeneity correlate with tumor grade, stage, molecular features, and survival.
- Current guidelines provide frameworks for chest and ancillary imaging in RCC management.
Conclusions:
- Integrating imaging-based prognostic markers with anatomical staging refines preoperative risk assessment in RCC.
- Advanced imaging technologies and standardized reporting systems (e.g., Kidney Imaging Reporting and Data System) hold promise for improved decision-making.
- Bridging imaging descriptors with prognostic phenotypes is essential for standardizing reports and enhancing patient care in RCC.
More Related Videos
Related Concept Videos
Cancer Survival Analysis
Imaging Studies V: Intravenous Urography and Retrograde Pyelography
Imaging Studies VII: Vascular Imaging
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Chronic Kidney Disease III: Interprofessional Care

